Literature DB >> 12907646

Mutations of APC, K-ras, and p53 are associated with specific chromosomal aberrations in colorectal adenocarcinomas.

Amy Leslie1, Norman R Pratt, Karen Gillespie, Mark Sales, Neil M Kernohan, Gillian Smith, C Roland Wolf, Francis A Carey, Robert J C Steele.   

Abstract

It is widely accepted that both large-scale chromosomal abnormalities and mutation of specific genes, such as APC, K-ras, and/or p53, occur in the majority of colorectal adenocarcinomas. Whether or not a relationship exists between these different forms of genetic abnormalities was previously unknown. Using comparative genomic hybridization and mutational analysis of APC, K-ras, and p53 to evaluate 50 colorectal adenocarcinomas, we have shown that mutation of p53 is significantly associated with gain of 20q, 13q, and 8q and loss of 18q (P = 0.000, 0.02, 0.044, and 0.001, respectively). Conversely, APC mutation did not associate with any of the above-mentioned aberrations but did associate significantly with gain of 7p (P = 0.01). Gain of chromosomal arm 12p, although a less common aberration, was significantly associated with K-ras mutation (P = 0.011). The associations we have described should refine the search for candidate genes underlying chromosomal aberrations and assist in the definition of distinct pathways in colorectal tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12907646

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  24 in total

1.  Aneuploidy arises at early stages of Apc-driven intestinal tumorigenesis and pinpoints conserved chromosomal loci of allelic imbalance between mouse and human.

Authors:  Paola Alberici; Emma de Pater; Joana Cardoso; Mieke Bevelander; Lia Molenaar; Jos Jonkers; Riccardo Fodde
Journal:  Am J Pathol       Date:  2007-01       Impact factor: 4.307

2.  Metabolic Imaging Phenotype Using Radiomics of [18F]FDG PET/CT Associated with Genetic Alterations of Colorectal Cancer.

Authors:  Shang-Wen Chen; Wei-Chih Shen; William Tzu-Liang Chen; Te-Chun Hsieh; Kuo-Yang Yen; Jan-Gowth Chang; Chia-Hung Kao
Journal:  Mol Imaging Biol       Date:  2019-02       Impact factor: 3.488

3.  The prognostic significance of K-ras, p53, and APC mutations in colorectal carcinoma.

Authors:  A Conlin; G Smith; F A Carey; C R Wolf; R J C Steele
Journal:  Gut       Date:  2005-04-20       Impact factor: 23.059

4.  Influence of age on adenomatous polyposis coli and p53 mutation frequency in sporadic colorectal cancer-rarity of co-occurrence of mutations in APC, K-ras, and p53 genes.

Authors:  Jy-Ming Chiang; Yah-Huei Wu Chou; Shih-Chieh Ma; Jim-Ray Chen
Journal:  Virchows Arch       Date:  2004-09-24       Impact factor: 4.064

5.  Activating K-Ras mutations outwith 'hotspot' codons in sporadic colorectal tumours - implications for personalised cancer medicine.

Authors:  G Smith; R Bounds; H Wolf; R J C Steele; F A Carey; C R Wolf
Journal:  Br J Cancer       Date:  2010-02-16       Impact factor: 7.640

6.  Differential expression of proteomics models of colorectal cancer, colorectal benign disease and healthy controls.

Authors:  Ming Liu; Chun-Feng Li; Hong-Sheng Chen; Luo-Qiang Lin; Chun-Peng Zhang; Jin-Lu Zhao; Yan Liu; Shu-Jun Zhang; Jun-Chao Jin; Lei Wang; Jia-Ren Liu
Journal:  Proteome Sci       Date:  2010-03-25       Impact factor: 2.480

7.  Does Mutated K-RAS Oncogene Attenuate the Effect of Sulindac in Colon Cancer Chemoprevention?

Authors:  Photini F S Rice; Kevin G Ehrichs; Mykella S Jones; Hwudarw Chen; Chiu-Hsieh Hsu; Edward R Abril; Raymond B Nagle; David G Besselsen; Jennifer K Barton; Natalia A Ignatenko
Journal:  Cancer Prev Res (Phila)       Date:  2017-11-08

8.  Association of survival and disease progression with chromosomal instability: a genomic exploration of colorectal cancer.

Authors:  Michal Sheffer; Manny D Bacolod; Or Zuk; Sarah F Giardina; Hanna Pincas; Francis Barany; Philip B Paty; William L Gerald; Daniel A Notterman; Eytan Domany
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-09       Impact factor: 11.205

9.  Blocking of p53-Snail binding, promoted by oncogenic K-Ras, recovers p53 expression and function.

Authors:  Sun-Hye Lee; Su-Jin Lee; Yeon Sang Jung; Yongbin Xu; Ho Sung Kang; Nam-Chul Ha; Bum-Joon Park
Journal:  Neoplasia       Date:  2009-01       Impact factor: 5.715

10.  Abnormal expression of TRIB3 in colorectal cancer: a novel marker for prognosis.

Authors:  N Miyoshi; H Ishii; K Mimori; Y Takatsuno; H Kim; H Hirose; M Sekimoto; Y Doki; M Mori
Journal:  Br J Cancer       Date:  2009-11-17       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.